Track Onconova Therapeutics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Onconova Therapeutics, Inc. ONTX · Stock Open Onconova Therapeutics, Inc. in new tab

6.89 USD
Target Price
8.33 USD
Loading chart...
Estimates
Target Mean Price8.33

DCF valuation

Model fair value for Onconova Therapeutics, Inc. (ONTX)
Result
Sign in to run the valuation for ONTX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 8.33 USD (low 7.00, high 11.00)
Low 7.00
Mean 8.33
High 11.00
Price 6.89
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Onconova Therapeutics, Inc. Logo Onconova Therapeutics, Inc. Analysis (ONTX)

United States Health Care Official Website Stock

Is Onconova Therapeutics, Inc. a good investment? Onconova Therapeutics, Inc. (ONTX) is currently trading at 6.89 USD. Market analysts have a consensus price target of 8.33 USD. This suggests a potential upside from current levels.

Investor FAQ

Does Onconova Therapeutics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Onconova Therapeutics, Inc.?

Onconova Therapeutics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Under normal circumstances, the fund will invest at least 80% of the value of its net assets, plus any borrowings for investment purposes, in financial instruments (for example, swaps and futures) that, in the aggregate, provide leveraged exposure to the Underlying Security equal to approximately two times its daily performance. It is non-diversified.

Exchange Ticker
NMS (United States) ONTX
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
June 1, 2016 1:10
Sept. 26, 2018 0.07
May 21, 2021 0.07
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion